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Use of platelet concentrate gel 
in second-intention wound healing: 
a case report
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Abstract 
Background: Wound healing is a complex and dynamic process. Healing of acute and chronic wounds can be 
impaired by patient factors (that is, comorbidities) and/or wound factors (that is, infection). Regenerative medicine 
products, such as autologous/homologous platelet-rich plasma gel, may speed up the healing process. Autologous/
homologous platelet-rich plasma is an advanced wound therapy used for hard-to-heal acute and chronic wounds. 
The cytokines and growth factors contained in platelet-rich plasma play a crucial role in the healing process.
Case presentation: A 61-year-old Caucasian male patient, suffering from mental retardation following meningitis, 
with a transplanted kidney due to prior renal impairment, and under immunosuppressant therapy, was submitted to 
aneurysmectomy of his proximal left forearm arteriovenous fistula. A few days later, the patient came to our attention 
with substantial blood loss from the surgical site. The wound presented no signs of healing, and after fistula repara-
tion and considering persistent infection of the surgical site (by methicillin-resistant Staphylococcus aureus), surgeons 
decided for second-intention healing. To favor healing, 10 mL homologous platelet concentrate gel was sequentially 
applied. After each application, wound was covered with nonadherent antiseptic dressing. After only seven applica-
tions of homologous platelet concentrate gel, wound completely recovered and no amputation was necessary.
Conclusions: Topical application of homologous platelet-rich plasma gel in healing wound shows beneficial results 
in wound size reduction and induces granulation tissue formation. Platelet-rich plasma could be a safe and cost-
effective treatment for managing the cutaneous wound healing process to shorten the recovery period and thereby 
improve patient quality of life.
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Background
Wound healing is a complex and dynamic process. Heal-
ing of acute and chronic wounds can become impaired by 
patient factors (that is, comorbidities) and/or wound fac-
tors (that is, infection). Regenerative medicine products, 
such as autologous/homologous platelet-rich plasma 
(PRP) gel, may speed up the healing process [1]. Autolo-
gous/homologous PRP is an advanced wound therapy 
used in hard-to-heal acute and chronic wounds. The 
cytokines and growth factors contained in PRP play a 
crucial role in the healing process.
Skin flap may help closure but can be affected by non-
healing skin ulcers. These ulcers are often slow healing 
and unresponsive to traditional treatments; consequently, 
the patient’s quality of life and prognosis may be severely 
affected [2]. To heal wounds resulting from skin transpo-
sition, local application of heterologous platelet-rich gel 
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(PRG) has already been attempted [3], and its efficacy 
demonstrated in both in vitro and in vivo models [4]. The 
great potential of platelet-based gel has already been dis-
cussed by several authors [5–8]. Platelet-derived growth 
factors are involved in tissue regeneration and formation 
of new vessels that could improve skin flap survival [9]. 
The reported case is in line with the Surgical Case Report 
(SCARE) criteria [10].
Case presentation
A 61-year-old Caucasian male patient came to our 
department complaining of two large venous aneurysms 
on his left cephalic and basilic veins. The patient suffered 
from end-stage renal disease and underwent right kidney 
transplantation and brachiocephalic arteriovenous fistula 
(AVF) creation, 10 and 13 years before admission, respec-
tively. The patient was poorly collaborative due to his cog-
nitive retardation, likely linkable to an improperly treated 
meningitis during childhood. He was also affected by 
hypertension and colonic diverticulosis. Five years before 
admission, deep vein thrombosis of the upper and lower 
limbs was reported. Interestingly, the patient followed 
an immunosuppressive therapy with everolimus, pred-
nisone, and mycophenolate mofetil. He also took ateno-
lol, ramipril, and amlodipin to control blood pressure, 
and clopidogrel with subcutaneous enoxaparin in rela-
tion to his medical history of hypercoagulation. Physical 
examination showed a 6 × 4  cm2 swelling of the proxi-
mal left forearm, with no alterations of the covering skin. 
Thrill was present at palpation. Auscultation revealed VI/
VI Levine systolic–diastolic bruit. Before intervention, 
informed consent was obtained from the patient’s legal 
representative and, only subsequently, was he premedi-
cated with intravenous cephazoline 1 g, administered one 
hour before skin incision. Surgery was performed under 
local anesthesia by means of mepivacaine 2%. A 10-cm 
incision was necessary to expose the fistula and the two 
outflow vein dilations. Cephalic vein aneurysm measured 
5 cm in length and 3 cm in transverse diameter, whereas 
the basilic vein aneurysmatic dilation was 3 cm long and 
2 cm wide (Fig. 1; Additional file 1: Video 1). After AVF 
closure and cephalic vein aneurysmectomy, the breach 
of the artery wall was closed with a 5-0 polypropylene 
suture. Basilic vein aneurysm was then excised, and the 
two vascular stumps were approached with a 5-0 poly-
propylene suture (Fig. 2; Additional file 2: Video 2). The 
patient was discharged after two days without compli-
cations. Twenty days later, the patient came back to our 
attention with substantial blood loss from the surgical 
site (Fig. 3). The left forearm was edematous, and the per-
ilesional skin showed signs of inflammation. The wound 
was not healed, and substance loss measured about 10 
cm in transverse diameter. Blood loss was stopped by 
Fig. 1 Left forearm. Intraoperative picture showing two aneurysms. 
The distal one is a cephalic vein aneurysm measuring 5 cm in length 
and 3 cm in transverse diameter; the proximal aneurysm represents 
the basilic vein aneurysmatic dilation (3 × 2  cm2)
Fig. 2 Left forearm. Intraoperative picture of the postoperative result. 
After AVF closure and cephalic vein aneurysmectomy, the breach of 
the artery wall was closed with a 5-0 polypropylene suture. Basilic 
vein aneurysm was then excised, and the two vascular stumps were 
approached with a 5-0 polypropylene suture
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means of a tourniquet; intravenous administration of cef-
triaxone 2 g was carried out, and the patient was imme-
diately conducted to the operating room. Intraoperative 
examination revealed purulent fluid collection at the sur-
gical site and a huge perivascular clot. Artery appeared 
inflamed and avascular. Debridement of the site caused 
substantial blood loss from proximal radial artery, close 
to the brachial artery bifurcation. After a failed attempt 
at vascular wall suture, considering the persistent infec-
tion of the surgical site (and the subsequent impossibil-
ity to use a vascular graft) and testing the patency of the 
ulnar artery, the radial artery was tied and completely 
closed. The area was cleared and, due to retracted skin 
margins, second-intention healing was chosen to restore 
normal local conditions (Fig.  4). The surgical site was 
treated with povidone iodine and covered with sterile 
gauzes. Daily medications were carried out for the next 2 
weeks. After surgery, the patient showed low hemoglobin 
blood levels, requiring blood transfusion. To favor heal-
ing, 14 days later, 10 mL homologous (due to constantly 
low blood hemoglobin levels) platelet concentrate gel 
was applied. After application, wound was covered with 
a nonadherent dressing. Before the procedure, wound 
swab was performed. Methicillin-resistant Staphylococ-
cus aureus (MRSA) colonies were detected, but no spe-
cific antibiotic therapy was established.
To prepare platelet concentrate gel, a unit of apheresis 
platelets from a type 0 periodic donor was used. The unit 
was aliquoted into 10 minibags of 20 mL each, and stored 
at a controlled temperature of –40 °C. Whenever a medi-
cation was performed, one minibag was thawed, divided 
into 10 dry tubes, and centrifuged at high speed (3500 
rpm) for 5 minutes to obtain a platelet pellet stratified at 
the bottom of each tube. Once the supernatant plasma 
(rich in anticoagulant) was removed, the pellet was sus-
pended in 10 cc of type  AB virus-inactivated plasma 
(universal plasma donor). To allow gelling of the plate-
let concentrate, the Plateltex  Act® kit was used. The full 
preparation of PRP gel took around 30 min.
Medications were performed once a week (as success-
fully attempted in other work [1]), for 7 weeks. Before 
applying the PRG, the wound was prepared by surgical 
debridement as required to remove any dead tissue and 
hyperkeratotic skin, then cleaned each time with saline 
Fig. 3 Left upper limb, 20 days after aneurysmectomy. The left forearm was edematous, and the perilesional skin showed signs of inflammation. 
The wound was not healed, and substance loss measured about 10 cm in transverse diameter. Blood loss was stopped by means of a tourniquet
Fig. 4 Left forearm. Surgical site soon after curettage and radial artery ligation. Loss of substance measures 6 × 4  cm2
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solution. After application, the wound was covered with 
nonadherent antiseptic dressing. A few layers of sterile 
gauze and noncompressible bandages were positioned 
on the region of interest. Clinical evaluation of the out-
come of treatment included assessment of the size of the 
ulcer and degree of wound healing. Percentage of reduc-
tion was calculated using the following equation: (wound 
dimensions before treatment − wound dimensions after 
treatment)/wound dimensions before treatment × 100.
After only seven applications of homologous plate-
let concentrate gel, wound completely recovered and no 
invasive surgical procedures were necessary. One week 
after the first application, the first granulation spots 
appeared (Fig. 5). At the second week, the wound meas-
ured 5 cm in transverse diameter and was 3 cm wide 
(Fig. 6). One week later, wound debridement showed that 
the granulation tissue covered the whole loss of substance 
Fig. 5 Left forearm. Skin wound 1 week after first treatment with 
PRG. First granulation spots appeared
Fig. 6 Left forearm. Skin wound at second control, before second PRG application. Loss of substance measures 5 × 3  cm2
Fig. 7 Left forearm skin wound. At third control (before third PRP application), the loss of substance measured 4.5 cm in transverse diameter and 
was 1.5 wide
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(Fig.  7) and wound edges appeared narrower (4.5 × 1.5 
 cm2). Five weeks after the first PRG application, the 
wound measured 3.5 × 0.7  cm2 (Fig. 8). After 2 months, 
the wound was completely recovered (Fig. 9). There were 
no complications recorded in the study (Additional Files 
1 and 2).
Discussion and conclusions
Satisfactory results have also been achieved on uremic 
and diabetic patients suffering from diabetic ulcers, with 
ulcer healing and a reduction of disease-associated mor-
bidity and decreased healthcare costs [11]. Our experi-
ence confirmed the utility of PRG for wound healing, 
particularly in a patient suffering from systemic sclerosis 
[1].
Several studies on the clinical use of PRP have already 
been conducted. Most of the literature ranges from den-
tal medicine [12] to maxillofacial surgery [13], from der-
matology and esthetic medicine [14, 15], to orthopedics 
and sports medicine [16], and even neurology [17]. PRP 
is also a promising therapeutic tool for the treatment 
of chronic mucositis [18] and for diabetic foot and leg 
ulcers [19]. In addition, PRP not only enhances the rate 
of wound healing but also reduces the neurological and 
neuropathic pain associated with injuries [20, 21]. Use 
of autologous platelet concentrates accelerates healing 
in dental implant surgery, orthopedic surgery, muscle 
and tendon repair, skin ulcers, hole repair in eye surgery, 
and cardiac surgery [22]. All these therapeutic properties 
are possible because platelet blood products are rich in 
growth factors and cytokines that stimulate and acceler-
ate the wound healing process. In their literature review, 
Zamani and colleagues well described all the biological 
properties of PRG and its clinical application [6]. Platelets 
have great potential to act in the three different processes 
involved in wound healing: inflammation, cell prolifera-
tion, and extracellular matrix remodeling. The content of 
their granules (neurotransmitters, enzymes, cytokines, 
growth factors, and chemokines) stimulates wound repa-
ration, increasing reepithelialization, contraction, and 
neovascularization. Platelets alone contain whatever is 
necessary for wound repair, and PRG guarantees the right 
amount of chemical signals to favor tissue regeneration. 
Furthermore, the presence of several enzymes (including 
lysozyme) exerts effective antimicrobial action [23].
Importantly, the preparation of PRG is cost-effective 
and relatively time-saving [24]. Furthermore, PRG is rela-
tively safe, with few side effects or complications, mainly 
related to hypersensitivity [25, 26].
A randomized clinical trial conducted by Elsaid et al. 
assessed the role of PRP gel on clean nonhealing dia-
betic foot ulcer. Those authors reported that 25% of 
treated patients achieved complete healing versus none 
of the control group (regular dressing with saline). In 
total, only 8.3% of the patients treated with PRG did not 
show any response to treatment [27]. Another recent 
randomized controlled trial by Raynis et al. compared 
the effectiveness of autologous PRP gel in the treatment 
of hard-to-heal leg ulcers with existing conventional 
treatment, revealing that 25.71% of the autologous PRP 
Fig. 8 Left forearm. Skin wound 9 weeks after surgery. The loss of 
substance was 3.5 × 0.7  cm2. No signs of bacterial infection are 
present
Fig. 9 Left forearm 2 months after first application of PRG and 10 
weeks after surgery. Complete recovery of the site is showed
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group and 17.64% of control group had ulcers com-
pletely reepithelialized (p > 0.05). Wound size reduction 
was 52.35% in the autologous PRP group and 33.36% 
in the control group (p =  0.003). The autologous PRP 
group showed superiority over conventional treatment 
in wound bed coverage with granulation (p  =  0.001) 
[28]. In the presented case, complete wound healing 
was achieved after only 6 weeks.
The percentage of reduction in the horizontal and 
longitudinal dimensions of the wound was 100%. This 
may reflect the growth-promoting effect of PRP gel.
Interestingly, despite the recorded presence of MRSA, 
use of PRG allowed to control surgical-site bacte-
rial colonization without antibiotic therapy, as already 
reported by several authors [29, 30].
Complicated skin wounds represent an increasingly 
hard challenge. To date, diabetes and long-standing dis-
eases have implied an aggressive surgical approach in 
most cases, with large curettages or even amputations. 
Regenerative medicine has offered several alternatives 
to invasive approaches, but is generally experimen-
tal and often very expensive. So far, PRP gel has been 
employed as a possible remedy to loss of substance in 
several branches of medicine. Unfortunately, experi-
ences are limited and there is not extensive clinical use. 
With this work, the effectiveness of platelet concen-
trate gel in repairing challenging skin loss of substance 
is underlined once more. Importantly, this is one of the 
few cases of a large skin wound (about 10 cm in maxi-
mum diameter) treated with weekly application of PRP 
gel, without skin graft covering. Restitutio ad integrum 
was complete and autonomous (second intention) in 
less than 2  months, without abnormal scarring out-
comes. Noninvasive procedures should always be cho-
sen, especially in cases like the presented one in which 
the patient is not totally compliant. Importantly, the 
procedure was cost-effective and easy to perform. Fur-
thermore, the antimicrobial properties of PRP against 
various microorganisms enable the potential use of PRP 
gel as an alternative to conventional antibiotics.
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